Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Minor version update from v3.3.3 to v3.3.4 with no changes to study content, eligibility criteria, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:30:05.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Locations section updated to include Pennsylvania as a site, replacing the prior 'Pennsylvania Locations' entry. The revision tag was updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-24T13:50:14.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added and v3.2.0 removed, indicating a minor metadata/version update in the page revision history with no impact on content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:49:56.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Removed the generic government funding lapse notice that warned about potential data delays and NIH operating status. This note did not pertain to the study data itself. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:33:34.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT03586024 between the old and new screenshots. Core elements such as eligibility criteria, study design, and key sections remain unchanged.
    Difference
    0.5%
    Check dated 2025-10-27T20:59:53.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T07:57:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.